To include your compound in the COVID-19 Resource Center, submit it here.

ABTL0812: Phase Ib data

An open-label, dose-escalation, Spanish Phase I/Ib trial in 29 patients with advanced solid tumors showed

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE